dr bennett's semaglutide FDA approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Tirzepatide vs. Semaglutide: What's the

ReisCEDreaJGDa CostaTH

This is the manufacturer telling you that beyond 21 days outside refrigeration, they cannot guarantee what you are injecting will work as intended

The study was partly open-label, which could have increased the risk of bias

The FDA approves semaglutide for chronic weight management in adults with a body mass index (BMI) of 30 kg/m or higher, or a BMI of 27 kg/m with at least one weight-related condition like type 2 diabetes, hypertension, or sleep apnea

Researchers found that the GLP-1 group did not have higher rates of gestational diabetes, severe maternal morbidity, or other adverse maternal outcomes, suggesting that the medication may have helped mitigate elevated risk factors